Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2017

Invite Credit Card Holder to pay

Requester Details

Credit Card Holder Details

Company Details

Message to be included

Peripheral Transluminal Coronary Angioplasty Balloons are used in procedures that help in restoring blood flow in the blocked coronary arteries by opening them. PTCA procedure helps in eliminating the requirement of open heart surgery. GlobalData's Medical Devices sector report, “Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2017" provides comprehensive information about the Peripheral Transluminal Coronary Angioplasty Balloons pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Scope

The Peripheral Transluminal Coronary Angioplasty Balloons Pipeline Assessment report provides key information and data related to:

  • Extensive coverage of the Peripheral Transluminal Coronary Angioplasty Balloons under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates.
  • Reviews of major players involved in the pipeline product development.
  • Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Peripheral Transluminal Coronary Angioplasty Balloons pipeline products.
  • Review of recent developments in the segment / industry.

Reasons to buy

The Peripheral Transluminal Coronary Angioplasty Balloons Pipeline Assessment report enables you to:

  • Access significant competitor information, analysis, and insights to improve your R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Transluminal Coronary Angioplasty Balloons under development.
  • Formulate market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

Companies mentioned

3DT Holdings, LLC

Aachen Resonance GmbH

Acrostak (Schweiz) AG

AlviMedica Medical Technologies Inc.

Andramed GmbH

Atrium Medical Corp

Bolton Medical Inc

Boston Scientific Corp

Cordis ...

3DT Holdings, LLC

Aachen Resonance GmbH

Acrostak (Schweiz) AG

AlviMedica Medical Technologies Inc.

Andramed GmbH

Atrium Medical Corp

Bolton Medical Inc

Boston Scientific Corp

Cordis Corp

Hatch Medical LLC

Innovia LLC

iVascular SLU

Kaneka Corp

Lithotech Medical Ltd

Medinol Ltd

Medtronic plc

Meril Life Sciences Pvt Ltd

MicroPort Scientific Corp

Natec Medical Ltd

Nexeon MedSystems Inc

QT Vascular Ltd

QualiMed Innovative Medizinprodukte GmbH

Sahajanand Medical Technologies Pvt Ltd

Terumo Corp

The Spectranetics Corp

VasoTech Inc.

Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 9

2.1 Peripheral Transluminal Coronary ...

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 9

2.1 Peripheral Transluminal Coronary Angioplasty Balloons Overview 9

3 Products under Development 10

3.1 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 10

3.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 11

3.3 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 12

3.4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 13

3.5 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 14

3.6 Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 15

4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products under Development by Companies 16

4.1 Peripheral Transluminal Coronary Angioplasty Balloons Companies - Pipeline Products by Stage of Development 16

4.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 18

5 Peripheral Transluminal Coronary Angioplasty Balloons Companies and Product Overview 19

5.1 3DT Holdings, LLC Company Overview 19

5.1.1 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 Aachen Resonance GmbH Company Overview 20

5.2.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Acrostak (Schweiz) AG Company Overview 21

5.3.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 AlviMedica Medical Technologies Inc. Company Overview 22

5.4.1 AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 Andramed GmbH Company Overview 23

5.5.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 23

5.6 Atrium Medical Corp Company Overview 24

5.6.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 24

5.7 Bolton Medical Inc Company Overview 25

5.7.1 Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.8 Boston Scientific Corp Company Overview 28

5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Cordis Corp Company Overview 30

5.9.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 Hatch Medical LLC Company Overview 31

5.10.1 Hatch Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.11 Innovia LLC Company Overview 32

5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 32

5.12 iVascular SLU Company Overview 33

5.12.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 33

5.13 Kaneka Corp Company Overview 34

5.13.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 34

5.14 Lithotech Medical Ltd Company Overview 36

5.14.1 Lithotech Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.15 Medinol Ltd Company Overview 37

5.15.1 Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.16 Medtronic plc Company Overview 38

5.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 38

5.17 Meril Life Sciences Pvt Ltd Company Overview 39

5.17.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.18 MicroPort Scientific Corp Company Overview 42

5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 Natec Medical Ltd Company Overview 44

5.19.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

5.20 Nexeon MedSystems Inc Company Overview 45

5.20.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 QT Vascular Ltd Company Overview 46

5.21.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.22 QualiMed Innovative Medizinprodukte GmbH Company Overview 50

5.22.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 50

5.23 Sahajanand Medical Technologies Pvt Ltd Company Overview 51

5.23.1 Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.24 Terumo Corp Company Overview 52

5.24.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 52

5.25 The Spectranetics Corp Company Overview 53

5.25.1 The Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 53

5.26 VasoTech Inc. Company Overview 55

5.26.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 55

6 Peripheral Transluminal Coronary Angioplasty Balloons- Recent Developments 56

6.1 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 56

6.2 Aug 17, 2017: Firefighter PTCA Balloon Catheter Gains Regulatory Approval in Argentina 58

6.3 Aug 14, 2017: Foxtrot Pro Obtain Regulatory Approval in Malaysia 59

6.4 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 59

6.5 Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 59

6.6 Aug 08, 2017: Nexeon Receives Research Grant from National Institutes of Health 63

6.7 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 64

6.8 Aug 03, 2017: Getinge to cooperate with Brazilian authorities on local ongoing investigations 64

6.9 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 64

6.10 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 65

6.11 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 66

6.12 Jul 24, 2017: Firefighter PTCA Balloon Catheter Gains CFDA Approval 67

6.13 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 68

6.14 Jul 17, 2017: Getinge appoints Lars Sandstrom as CFO and Member of Getinge Executive Team 68

6.15 Jul 17, 2017: Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M 69

6.16 Jul 17, 2017: Getinge: Interim Report January – June 2017 69

6.17 Jul 07, 2017: MPSC New COO Glendy Wang on Board 69

6.18 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 70

6.19 Jun 24, 2017: Investigation by the Brazilian Administrative Council for Economic Defense comprises two Getinge entities 72

6.20 Jun 21, 2017: TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart Drug-Coated Coronary Balloon 72

6.21 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 73

6.22 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 73

6.23 Jun 06, 2017: OrbusNeich Announces FDA Clearance, Launch of Sapphire II PRO 74

6.24 Jun 06, 2017: OrbusNeich Announces FDA Clearance, Launch of Sapphire NC Plus Coronary Dilatation Catheter 74

6.25 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 75

6.26 May 23, 2017: MicroPort Listed as Enterprises Conforming to CSR Standards for Six Consecutive Years 78

6.27 May 12, 2017: Abbott Initiates Voluntarily Recall of Specific Lots of NC Trek RX Coronary Dilatation Catheter 78

6.28 May 12, 2017: Abbott Initiates Voluntarily Recall of NC Tenku RX PTCA Balloon Catheter 79

6.29 May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 79

6.30 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 81

6.31 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 82

6.32 Apr 25, 2017: Getinge: Interim Report January-March 2017 83

6.33 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 83

6.34 Apr 20, 2017: Chief Financial Officer leaves Getinge 85

6.35 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 85

6.36 Mar 31, 2017: B. Braun continues its sales and earnings growth 85

6.37 Mar 30, 2017: MPSC Announces 2016 Annual Results 87

6.38 Mar 29, 2017: Resolutions at Getinge’s Annual General Meeting 2017 88

6.39 Mar 23, 2017: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 89

6.40 Mar 21, 2017: The new Getinge logo – inspired by the star of life 93

6.41 Mar 20, 2017: Getinge establishes new brand structure and becomes a single brand company 93

6.42 Mar 15, 2017: Getinge to exhibit full product portfolio for Intensive Care Units at International Symposium on Intensive Care and Emergency Medicine (ISICEM) 93

6.43 Mar 10, 2017: Neovasc Announces TSX Symbol Change to NVCN 94

6.44 Feb 25, 2017: FOXTROT NC PTCA Balloon Catheter Gains Regulatory Approval in Mexico 94

6.45 Feb 23, 2017: Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million 95

6.46 Feb 22, 2017: Change in the B. Braun Management Board 95

6.47 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 96

6.48 Feb 16, 2017: Medinol Announces Appointment Of Harvey J. Berger, M.D., As Executive Chairman Of Medinol US 98

6.49 Feb 09, 2017: Terumo Announces Change of Executive Officers 99

6.50 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 100

6.51 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 101

6.52 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 102

6.53 Jan 31, 2017: Terumo Opens a Branch in Yangon 104

6.54 Jan 26, 2017: Getinge Year-End Report January-December 2016 104

6.55 Jan 18, 2017: Neovasc Announces Update in Litigation with CardiAQ 104

6.56 Jan 15, 2017: Getinge Group to exhibit complete product portfolio at Arab Health 105

6.57 Jan 11, 2017: OrbusNeich Expands Portfolio with a Next Generation Coronary Scoring Balloon 105

6.58 Jan 11, 2017: Spectranetics Names Scott Hutton as General Manager, Vascular Intervention 106

6.59 Jan 10, 2017: US Endovascular Announces John F. Vacha & Paul A. Tyska Join The Partnership 107

6.60 Dec 28, 2016: MicroPort was selected as a pilot project of Patent Alliance of Enterprises in Shanghai Zhangjiang National Innovation Demonstration Zone 107

6.61 Dec 19, 2016: MicroPort Endovascular Received CE Mark Approval for Hercules Balloon Dilation Catheter 108

6.62 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 108

6.63 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 109

6.64 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 110

6.65 Nov 16, 2016: iVascular announces that NC Xperience – non-compliant dilatation catheter – has received CE mark approval 113

6.66 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 114

6.67 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 114

6.68 Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016 115

6.69 Nov 03, 2016: Mattias Perjos appointed President and CEO of Getinge Group 117

6.70 Oct 27, 2016: Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million 118

6.71 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 119

6.72 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 120

6.73 Oct 18, 2016: Further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge 122

6.74 Oct 18, 2016: Getinge Interim Report January-September 2016 123

6.75 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 126

6.76 Sep 27, 2016: MicroPort Hosts First EMEA Regional Distributor Summit 126

6.77 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 127

7 Appendix 129

7.1 Methodology 129

7.2 About GlobalData 132

7.3 Contact Us 132

7.4 Disclaimer 132

List of tables

Table 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 10

Table 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment ...

Table 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 10

Table 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 11

Table 3: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 12

Table 4: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 13

Table 5: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 14

Table 6: Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 15

Table 7: PTCA Balloons Companies - Pipeline Products by Stage of Development 16

Table 8: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 18

Table 9: 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 19

Table 12: Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 20

Table 15: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 21

Table 18: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

Table 21: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 23

Table 24: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Table 27: Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 34: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28

Table 41: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 30

Table 44: Hatch Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 31

Table 47: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 32

Table 50: iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 33

Table 53: Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 34

Table 58: Lithotech Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Table 61: Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Table 64: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 67: Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Table 72: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 42

Table 79: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

Table 82: Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 85: QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Table 92: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 50

Table 95: Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Table 98: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 52

Table 101: The Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 53

Table 106: VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 55

Table 109: Glossary 131

List of figures

Figure 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 10

Figure 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment ...

Figure 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 10

Figure 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 11

Figure 3: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 12

Figure 4: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 13

Figure 5: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 14

Figure 6: Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 15

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports